BACKGROUND: Aortic stenosis in the midgestation fetus with a normal-sized or dilated left ventricle predictably progresses to hypoplastic left heart syndrome when associated with certain physiological findings. Prenatal balloon aortic valvuloplasty may improve left heart growth and function, possibly preventing evolution to hypoplastic left heart syndrome. METHODS AND RESULTS: Between March 2000 and October 2008, 70 fetuses underwent attempted aortic valvuloplasty for critical aortic stenosis with evolving hypoplastic left heart syndrome. We analyzed this experience to determine factors associated with procedural and postnatal outcome. The median gestational age at intervention was 23 weeks. The procedure was technically successful in 52 fetuses (74%). Relative to 21 untreated comparison fetuses, subsequent prenatal growth of the aortic and mitral valves, but not the left ventricle, was improved after intervention. Nine pregnancies (13%) did not reach a viable term or preterm birth. Seventeen patients had a biventricular circulation postnatally, 15 from birth. Larger left heart structures and higher left ventricular pressure at the time of intervention were associated with biventricular outcome. A multivariable threshold scoring system was able to discriminate fetuses with a biventricular outcome with 100% sensitivity and modest positive predictive value. CONCLUSIONS: Technically successful aortic valvuloplasty alters left heart valvar growth in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome and, in a subset of cases, appeared to contribute to a biventricular outcome after birth. Fetal aortic valvuloplasty carries a risk of fetal demise. Fetuses undergoing in utero aortic valvuloplasty with an unfavorable multivariable threshold score at the time of intervention are very unlikely to achieve a biventricular circulation postnatally.
BACKGROUND:Aortic stenosis in the midgestation fetus with a normal-sized or dilated left ventricle predictably progresses to hypoplastic left heart syndrome when associated with certain physiological findings. Prenatal balloon aortic valvuloplasty may improve left heart growth and function, possibly preventing evolution to hypoplastic left heart syndrome. METHODS AND RESULTS: Between March 2000 and October 2008, 70 fetuses underwent attempted aortic valvuloplasty for critical aortic stenosis with evolving hypoplastic left heart syndrome. We analyzed this experience to determine factors associated with procedural and postnatal outcome. The median gestational age at intervention was 23 weeks. The procedure was technically successful in 52 fetuses (74%). Relative to 21 untreated comparison fetuses, subsequent prenatal growth of the aortic and mitral valves, but not the left ventricle, was improved after intervention. Nine pregnancies (13%) did not reach a viable term or preterm birth. Seventeen patients had a biventricular circulation postnatally, 15 from birth. Larger left heart structures and higher left ventricular pressure at the time of intervention were associated with biventricular outcome. A multivariable threshold scoring system was able to discriminate fetuses with a biventricular outcome with 100% sensitivity and modest positive predictive value. CONCLUSIONS: Technically successful aortic valvuloplasty alters left heart valvar growth in fetuses with aortic stenosis and evolving hypoplastic left heart syndrome and, in a subset of cases, appeared to contribute to a biventricular outcome after birth. Fetal aortic valvuloplasty carries a risk of fetal demise. Fetuses undergoing in utero aortic valvuloplasty with an unfavorable multivariable threshold score at the time of intervention are very unlikely to achieve a biventricular circulation postnatally.
Authors: Audrey C Marshall; Mary E van der Velde; Wayne Tworetzky; Carlen A Gomez; Louise Wilkins-Haug; Carol B Benson; Russell W Jennings; James E Lock Journal: Circulation Date: 2004-06-28 Impact factor: 29.690
Authors: T Kohl; G Sharland; L D Allan; U Gembruch; R Chaoui; L M Lopes; P Zielinsky; J Huhta; N H Silverman Journal: Am J Cardiol Date: 2000-05-15 Impact factor: 2.778
Authors: G K Lofland; B W McCrindle; W G Williams; E H Blackstone; C I Tchervenkov; R Sittiwangkul; R A Jonas Journal: J Thorac Cardiovasc Surg Date: 2001-01 Impact factor: 5.209
Authors: Wayne Tworetzky; Louise Wilkins-Haug; Russell W Jennings; Mary E van der Velde; Audrey C Marshall; Gerald R Marx; Steven D Colan; Carol B Benson; James E Lock; Stanton B Perry Journal: Circulation Date: 2004-10-04 Impact factor: 29.690
Authors: James S Tweddell; George M Hoffman; Kathleen A Mussatto; Raymond T Fedderly; Stuart Berger; Robert D B Jaquiss; Nancy S Ghanayem; Stephanie J Frisbee; S Bert Litwin Journal: Circulation Date: 2002-09-24 Impact factor: 29.690
Authors: Arielle Mizrahi-Arnaud; Wayne Tworetzky; Linda A Bulich; Louise E Wilkins-Haug; Audrey C Marshall; Carol B Benson; James E Lock; Doff B McElhinney Journal: Pediatr Res Date: 2007-09 Impact factor: 3.756
Authors: Ashwin Prakash; Thomas G Travison; Mark A Fogel; Lynne M Hurwitz; Andrew J Powell; Beth F Printz; Michael D Puchalski; Girish S Shirali; Shi-Joon Yoo; Tal Geva Journal: Am J Cardiol Date: 2010-12-01 Impact factor: 2.778
Authors: L R Freud; A Moon-Grady; M C Escobar-Diaz; N L Gotteiner; L T Young; D B McElhinney; W Tworetzky Journal: Ultrasound Obstet Gynecol Date: 2015-01-28 Impact factor: 7.299
Authors: Kevin G Friedman; David Schidlow; Lindsay Freud; Maria Escobar-Diaz; Wayne Tworetzky Journal: Am J Cardiol Date: 2014-04-18 Impact factor: 2.778
Authors: Melanie Vogel; Louise E Wilkins-Haug; Doff B McElhinney; Audrey C Marshall; Carol B Benson; Virginia Silva; Wayne Tworetzky Journal: Fetal Diagn Ther Date: 2009-12-17 Impact factor: 2.587
Authors: Doff B McElhinney; Carol B Benson; David W Brown; Louise E Wilkins-Haug; Audrey C Marshall; Linda Zaccagnini; Wayne Tworetzky Journal: Ultrasound Med Biol Date: 2010-01 Impact factor: 2.998